Cargando…

The Effect of Neutral Peritoneal Dialysis Solution with Low Glucose-Degradation-Product on the Fluid Status and Body Composition – A Randomized Control Trial

BACKGROUND: Previous studies report conflicting results on the benefit of peritoneal dialysis (PD) patients treated with low glucose degradation product (GDP) solution. The effects of low GDP solution on body fluid status and arterial pulse wave velocity (PWV) have not been studied. METHODS: We rand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szeto, Cheuk-Chun, Kwan, Bonnie C. H., Chow, Kai-Ming, Cheng, Phyllis M. S., Kwong, Vickie W. K., Choy, Agnes S. M., Law, Man-Ching, Leung, Chi-Bon, Li, Philip K. T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625015/ https://www.ncbi.nlm.nih.gov/pubmed/26510186 http://dx.doi.org/10.1371/journal.pone.0141425

Ejemplares similares

The efficacy of managing fluid overload in chronic peritoneal dialysis patients by a structured nurse-led intervention protocol
por: Law, Man Ching, et al.
Publicado: (2019)

Asymptomatic fluid overload predicts survival and cardiovascular event in incident Chinese peritoneal dialysis patients
por: Ng, Jack Kit-Chung, et al.
Publicado: (2018)

Depression does not predict clinical outcome of Chinese peritoneal Dialysis patients after adjusting for the degree of frailty
por: Chan, Gordon Chun-Kau, et al.
Publicado: (2020)

Newer antibiotics for the treatment of peritoneal dialysis-related peritonitis
por: Ma, Terry King-Wing, et al.
Publicado: (2016)

Interaction between central obesity and frailty on the clinical outcome of peritoneal dialysis patients
por: Chan, Gordon Chun-Kau, et al.
Publicado: (2020)

Peritoneal dialysis-related peritonitis caused by Pseudomonas species: Insight from a post-millennial case series
por: Lu, Wanhong, et al.
Publicado: (2018)

Excessive risk and poor outcome of hospital-acquired peritoneal dialysis-related peritonitis
por: Szeto, Cheuk-Chun, et al.
Publicado: (2022)

Longitudinal Changes of NF-κB Downstream Mediators and Peritoneal Transport Characteristics in Incident Peritoneal Dialysis Patients
por: Fung, Winston Wing-Shing, et al.
Publicado: (2020)

Metabolic syndrome in peritoneal dialysis patients
por: Li, Philip Kam-Tao, et al.
Publicado: (2008)

Obesity, Weight Gain, and Fluid Overload in Peritoneal Dialysis
por: Ng, Jack Kit-Chung, et al.
Publicado: (2022)

Clinical manifestation of macrolide antibiotic toxicity in CKD and dialysis patients
por: Ma, Terry King-Wing, et al.
Publicado: (2014)

Relation between MicroRNA Expression in Peritoneal Dialysis Effluent and Peritoneal Transport Characteristics
por: Chen, Jin, et al.
Publicado: (2012)

Adipose and Plasma microRNAs miR-221 and 222 Associate with Obesity, Insulin Resistance, and New Onset Diabetes after Peritoneal Dialysis
por: Chan, Gordon Chun Kau, et al.
Publicado: (2022)

Extended antibiotic therapy for the prevention of relapsing and recurrent peritonitis in peritoneal dialysis patients: a randomized controlled trial
por: Szeto, Cheuk-Chun, et al.
Publicado: (2021)

Peritoneal dialysis after failed kidney allograft: Comparing patients with and without pd before transplant
por: Tian, Na, et al.
Publicado: (2023)

Circulating Bacterial-Derived DNA Fragment Level Is a Strong Predictor of Cardiovascular Disease in Peritoneal Dialysis Patients
por: Szeto, Cheuk-Chun, et al.
Publicado: (2015)

Circulating and Adipose Tissue Adiponectin Level and Outcomes in Incident Peritoneal Dialysis Patients
por: Than, Win Hlaing, et al.
Publicado: (2022)

Pharmacokinetics of Apixaban Among Peritoneal Dialysis Patients
por: Fung, Winston Wing-Shing, et al.
Publicado: (2023)

Relationship between Serial Serum Neutrophil-Lymphocyte Ratio, Cardiovascular Mortality, and All-Cause Mortality in Chinese Peritoneal Dialysis Patients
por: Lau, Lik Fung Sam, et al.
Publicado: (2023)

Change in bacterial aetiology of peritoneal dialysis-related peritonitis over 10 years: experience from a centre in south-east Asia
por: Szeto, C.-C., et al.
Publicado: (2005)

Omentin-1 Levels and Outcomes in Incident Peritoneal Dialysis Patients
por: Than, Win Hlaing, et al.
Publicado: (2023)

Plasma vaspin levels and clinical outcome in incident peritoneal dialysis patients
por: Than, Win Hlaing, et al.
Publicado: (2023)

Cytotoxic Glucose Degradation Products in Fluids for Peritoneal Dialysis
por: Adib, Noushin, et al.
Publicado: (2011)

Impact of Weight Gain on the Subsequent Survival of New Peritoneal Dialysis Patients
por: Than, Win Hlaing, et al.
Publicado: (2023)

The Impact of Volume Overload on the Longitudinal Change of Adipose and Lean Tissue Mass in Incident Chinese Peritoneal Dialysis Patients
por: Ng, Jack Kit-Chung, et al.
Publicado: (2022)

Adipose and serum zinc alpha-2-glycoprotein (ZAG) expressions predict longitudinal change of adiposity, wasting and predict survival in dialysis patients
por: Chan, Gordon Chun-Kau, et al.
Publicado: (2022)

The Safety and Short-Term Efficacy of Aliskiren in the Treatment of Immunoglobulin A Nephropathy – A Randomized Cross-Over Study
por: Szeto, Cheuk-Chun, et al.
Publicado: (2013)

The change in the prevalence of obesity and new-onset diabetes in Chinese peritoneal dialysis patients over 25 years
por: Than, Win Hlaing, et al.
Publicado: (2021)

Peritoneal Adipocytes and Their Role in Inflammation during Peritoneal Dialysis
por: Lai, Kar Neng, et al.
Publicado: (2010)

Degradation and de novo formation of nine major glucose degradation products during storage of peritoneal dialysis fluids
por: Gensberger-Reigl, Sabrina, et al.
Publicado: (2022)

Establishing a Core Outcome Measure for Peritoneal Dialysis-related Peritonitis: A Standardized Outcomes in Nephrology—Peritoneal Dialysis Consensus Workshop Report
por: Shen, Jenny I., et al.
Publicado: (2022)

Biocompatible Peritoneal Dialysis Fluids: Clinical Outcomes
por: Cho, Yeoungjee, et al.
Publicado: (2012)

Is there such a thing as biocompatible peritoneal dialysis fluid?
por: Schmitt, Claus Peter, et al.
Publicado: (2016)

Evaluation of a Fourth-Generation Subcutaneous Real-Time Continuous Glucose Monitor (CGM) in Individuals With Diabetes on Peritoneal Dialysis
por: Ng, Jack K.C., et al.
Publicado: (2023)

Peritoneal Fluid Transport rather than Peritoneal Solute Transport Associates with Dialysis Vintage and Age of Peritoneal Dialysis Patients
por: Waniewski, Jacek, et al.
Publicado: (2016)

Anemia Management in Peritoneal Dialysis: Perspectives From the Asia Pacific Region
por: Li, Philip Kam Tao, et al.
Publicado: (2021)

Peritoneal dialysis fluid biocompatibility impact on human peritoneal membrane permeability
por: Rodríguez-Esparragón, Francisco, et al.
Publicado: (2018)

Compatibility of aztreonam in four commercial peritoneal dialysis fluids
por: Tobudic, Selma, et al.
Publicado: (2020)

Severe acute respiratory syndrome in a hemodialysis patient
por: Kwan, Bonnie Ching-Ha, et al.
Publicado: (2003)

Optimal peritoneal fluid white blood cell count for diagnosis of peritonitis in peritoneal dialysis patients
por: Kunin, Margarita, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e31ma4m0ehbndndf9ee6vcbunu